Celltrion won in the appellate courts in patent dispute over the trademark right of rheumatoid arthritis Remsima between Janssen

Celltrion won in the appellate courts in patent dispute over the trademark right of rheumatoid arthritis Remsima between Janssen. Janssen had filed a nullity trial of Remsima with the reason that Celltrion's biosimilar Remsima infringed patent right of Remicade.

On August 24, according to the related industry, the patent court ruled against Janssen that filed a nullity trial of Remsima's paten...